Last reviewed · How we verify
Ocular Tissue Levels of 1.5% Levofloxacin Ophthalmic Solution Compared to an Active Comparator
Compare ocular tissue levels following topical ocular instillation of 1.5% levofloxacin ophthalmic solution or an active comparator in subjects undergoing cataract surgery.
Details
| Lead sponsor | Santen Inc. |
|---|---|
| Phase | Phase 4 |
| Status | COMPLETED |
| Enrolment | 96 |
| Start date | 2008-02 |
Conditions
- Cataract
Interventions
- 1.5% levofloxacin ophthalmic solution
- 0.5% moxifloxacin hydrochloride ophthalmic solution
Primary outcomes
- Concentration of levofloxacin and active control in the aqueous humor — Time of surgery
Countries
United States